Search details
1.
APOLD1 loss causes endothelial dysfunction involving cell junctions, cytoskeletal architecture, and Weibel-Palade bodies, while disrupting hemostasis.
Haematologica
; 108(3): 772-784, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-35638551
2.
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.
Haemophilia
; 27(6): 911-920, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34614267
3.
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.
Haemophilia
; 27(6): 921-931, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34636112
4.
Investigator clinical trials: How can we ask the question?
Haemophilia
; 26 Suppl 3: 20-21, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-32356344
5.
Inherited or acquired modifiers of iron status may dramatically affect the phenotype in dehydrated hereditary stomatocytosis.
Eur J Haematol
; 101(4): 566-569, 2018 Oct.
Article
in English
| MEDLINE | ID: mdl-29969830
6.
The role of genetic factors in patients with hepatocellular carcinoma and iron overload - a prospective series of 234 patients.
Liver Int
; 36(5): 746-54, 2016 05.
Article
in English
| MEDLINE | ID: mdl-26474245
7.
Major surgery management in patients with haemophilia A and inhibitors on emicizumab prophylaxis without global coagulation monitoring.
Br J Haematol
; 189(3): e100-e103, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32087028
8.
[Congenital haemorrhagic diseases]. / MALADIES HÉMORRAGIQUES CONSTITUTIONNELLES.
Rev Prat
; 65(5): 613-7, 2015 May.
Article
in French
| MEDLINE | ID: mdl-26165091
9.
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database.
Blood Adv
; 8(6): 1392-1404, 2024 Mar 26.
Article
in English
| MEDLINE | ID: mdl-38286442
10.
Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study.
Circulation
; 125(25): 3201-10, 2012 Jun 26.
Article
in English
| MEDLINE | ID: mdl-22615340
11.
A follow-up study of a genome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24.1.
Am J Hum Genet
; 86(4): 592-5, 2010 Apr 09.
Article
in English
| MEDLINE | ID: mdl-20226436
12.
Pre-interventional haemostatic assessment: Guidelines from the French Society of Anaesthesia and Intensive Care.
Eur J Anaesthesiol
; 30(4): 142-62, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23435255
13.
A new high affinity variant Hb Aurillac (ß141LeuâVal).
Hemoglobin
; 37(6): 584-8, 2013.
Article
in English
| MEDLINE | ID: mdl-23859762
14.
Surgery in rare bleeding disorders: the prospective MARACHI study.
Res Pract Thromb Haemost
; 7(7): 102199, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-37867585
15.
Idiopathic purpura fulminans associated with anti-protein S antibodies in children: a multicenter case series and systematic review.
Blood Adv
; 6(2): 495-502, 2022 01 25.
Article
in English
| MEDLINE | ID: mdl-34788405
16.
Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A.
Hum Gene Ther
; 33(7-8): 432-441, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35156839
17.
Discontinuous epitopes on the C2 domain of coagulation Factor VIII mapped by computer-designed synthetic peptides.
Br J Haematol
; 155(4): 487-97, 2011 Nov.
Article
in English
| MEDLINE | ID: mdl-21933172
18.
Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER.
Br J Haematol
; 152(3): 340-6, 2011 Feb.
Article
in English
| MEDLINE | ID: mdl-21158750
19.
SULFs in human neoplasia: implication as progression and prognosis factors.
J Transl Med
; 9: 72, 2011 May 21.
Article
in English
| MEDLINE | ID: mdl-21599997
20.
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach.
Blood
; 113(21): 5298-303, 2009 May 21.
Article
in English
| MEDLINE | ID: mdl-19278955